IMPLANON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Implanon, and what generic alternatives are available?
Implanon is a drug marketed by Organon and is included in one NDA. There is one patent protecting this drug.
This drug has thirty-three patent family members in twenty-seven countries.
The generic ingredient in IMPLANON is etonogestrel. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the etonogestrel profile page.
DrugPatentWatch® Generic Entry Outlook for Implanon
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be September 28, 2027. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
Summary for IMPLANON
International Patents: | 33 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 60 |
Clinical Trials: | 25 |
Patent Applications: | 2,161 |
Formulation / Manufacturing: | see details |
DailyMed Link: | IMPLANON at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for IMPLANON
Generic Entry Date for IMPLANON*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
IMPLANT;IMPLANTATION |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for IMPLANON
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Eastern Virginia Medical School | Phase 4 |
CONRAD | Phase 4 |
United States Agency for International Development (USAID) | Phase 4 |
Pharmacology for IMPLANON
Drug Class | Progestin |
Anatomical Therapeutic Chemical (ATC) Classes for IMPLANON
US Patents and Regulatory Information for IMPLANON
IMPLANON is protected by one US patents.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of IMPLANON is ⤷ Try a Trial.
This potential generic entry date is based on patent ⤷ Try a Trial.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Patents protecting IMPLANON
Applicator for inserting an implant
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: PREVENTION OF PREGNANCY
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon | IMPLANON | etonogestrel | IMPLANT;IMPLANTATION | 021529-001 | Jul 17, 2006 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for IMPLANON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon | IMPLANON | etonogestrel | IMPLANT;IMPLANTATION | 021529-001 | Jul 17, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon | IMPLANON | etonogestrel | IMPLANT;IMPLANTATION | 021529-001 | Jul 17, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for IMPLANON
When does loss-of-exclusivity occur for IMPLANON?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
Egypt
Patent: 359
Estimated Expiration: ⤷ Try a Trial
Latvia
Patent: 521
Estimated Expiration: ⤷ Try a Trial
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering IMPLANON around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 1841492 | APPAREIL DE POSE D'IMPLANT (APPLICATOR FOR INSERTING AN IMPLANT) | ⤷ Try a Trial |
South Africa | 200705955 | Applicator for inserting an implant | ⤷ Try a Trial |
Australia | 603475 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for IMPLANON
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0303306 | 099C0041 | Belgium | ⤷ Try a Trial | PRODUCT NAME: ETONOGESTREL; NATL. REGISTRATION NO/DATE: 52 IS 296 F 14 19990531; FIRST REGISTRATION: NL RVG 21168 19980825 |
0303306 | 29/1999 | Austria | ⤷ Try a Trial | PRODUCT NAME: ETONOGESTREL; NAT. REGISTRATION NO/DATE: 1-22964 19990330; FIRST REGISTRATION: NL 21168 19980825 |
0303306 | SPC/GB99/044 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ETONOGESTREL; REGISTERED: NL RGV21168 19980825; UK 00065/0161 19990609 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |